Recalls / Class II
Class IID-0469-2021
Product
PREGABALIN CAPSULES 300MG 90 ; NDC 43598-298-90; RX; CAPSULES
- Brand name
- Pregabalin
- Generic name
- Pregabalin
- Active ingredient
- Pregabalin
- Route
- Oral
- NDCs
- 43598-291, 43598-292, 43598-293, 43598-294, 43598-295, 43598-296, 43598-297, 43598-298
- FDA application
- ANDA209664
- Affected lot / code info
- T2000309
Why it was recalled
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalling firm
- Firm
- Cardinal Health Inc.
- Manufacturer
- Dr.Reddys Laboratories Inc
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091
Distribution
- Quantity
- 6 CONTAINERS
- Distribution pattern
- FL, GA, SC
Timeline
- Recall initiated
- 2021-03-15
- FDA classified
- 2021-05-24
- Posted by FDA
- 2021-06-02
- Terminated
- 2024-06-17
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0469-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.